Contrast-enhanced fluid-attenuated inversion-recovery (FLAIR) versus contrast-enhanced T1 MRI in the evaluation of intracranial tumors: A comparative study

Q4 Medicine
Q. Hassan
{"title":"Contrast-enhanced fluid-attenuated inversion-recovery (FLAIR) versus contrast-enhanced T1 MRI in the evaluation of intracranial tumors: A comparative study","authors":"Q. Hassan","doi":"10.4314/rmj.v79i4.4","DOIUrl":null,"url":null,"abstract":"INTRODUCTION: At most institutions, the favored contrast MR sequence is T1-weighted imaging (T1WI). However, lesion enhancement is occasionally inconspicuous on T1WI.Objective: This study aims to evaluate the diagnostic value of contrast-enhanced FLAIR compared to contrast-enhanced T1WI for intracranial tumors and to offer data for further clinical judgment. METHODS: 88 consecutive cases of intracranial tumors referred for contrast-enhanced brain MRI were analyzed. FLAIR and T1 were used alternately in equal percentages as the first contrast-enhanced sequence to avoid delayed contrast-enhancement effects of the lesions. Six quantitative criteria were considered: lesion-to-white matter contrast ratio (CR) and contrast-to-noise ratio (CNR), lesion-to-gray matter CR and CNR, and lesion-to-cerebrospinal fluid CR and CNR. For qualitative evaluation, two experienced radiologists assessed lesion conspicuity on contrast-enhanced-T1WI and FLAIR sequences using the following three scales: 1, FLAIR superior; 2, sequences equal; 3, T1 superior. RESULTS: For quantitative measurement, the contrast enhanced-FLAIR lesion-to-white matter, lesion-to-cerebrospinal fluid CR, and CNR values were statistically superior to those of the contrast enhanced-T1 weighted images (p = 0.001 in all). However, lesion-to-gray matter CR and CNR were slightly higher on CE-FLAIR, but with no statistically significant difference (p = 0.159, 0.184, respectively). For qualitative evaluation, both radiologists assessed that contrast enhanced-FLAIR images were superior to contrast enhanced-T1 weighted images for the evaluation of lesion conspicuity, especially when it was performed as the second sequence. CONCLUSION: FLAIR sequence was superior or comparable to T1 sequence, especially when performed as a second post-contrast sequence. Using contrast enhanced-FLAIR as a routine MRI sequence will increase diagnostic confidence.","PeriodicalId":38181,"journal":{"name":"Rwanda Medical Journal","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2022-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Rwanda Medical Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4314/rmj.v79i4.4","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

INTRODUCTION: At most institutions, the favored contrast MR sequence is T1-weighted imaging (T1WI). However, lesion enhancement is occasionally inconspicuous on T1WI.Objective: This study aims to evaluate the diagnostic value of contrast-enhanced FLAIR compared to contrast-enhanced T1WI for intracranial tumors and to offer data for further clinical judgment. METHODS: 88 consecutive cases of intracranial tumors referred for contrast-enhanced brain MRI were analyzed. FLAIR and T1 were used alternately in equal percentages as the first contrast-enhanced sequence to avoid delayed contrast-enhancement effects of the lesions. Six quantitative criteria were considered: lesion-to-white matter contrast ratio (CR) and contrast-to-noise ratio (CNR), lesion-to-gray matter CR and CNR, and lesion-to-cerebrospinal fluid CR and CNR. For qualitative evaluation, two experienced radiologists assessed lesion conspicuity on contrast-enhanced-T1WI and FLAIR sequences using the following three scales: 1, FLAIR superior; 2, sequences equal; 3, T1 superior. RESULTS: For quantitative measurement, the contrast enhanced-FLAIR lesion-to-white matter, lesion-to-cerebrospinal fluid CR, and CNR values were statistically superior to those of the contrast enhanced-T1 weighted images (p = 0.001 in all). However, lesion-to-gray matter CR and CNR were slightly higher on CE-FLAIR, but with no statistically significant difference (p = 0.159, 0.184, respectively). For qualitative evaluation, both radiologists assessed that contrast enhanced-FLAIR images were superior to contrast enhanced-T1 weighted images for the evaluation of lesion conspicuity, especially when it was performed as the second sequence. CONCLUSION: FLAIR sequence was superior or comparable to T1 sequence, especially when performed as a second post-contrast sequence. Using contrast enhanced-FLAIR as a routine MRI sequence will increase diagnostic confidence.
对比增强液体衰减反转恢复(FLAIR)与对比增强T1 MRI在颅内肿瘤评估中的比较研究
简介:在大多数机构,首选的对比MR序列是T1加权成像(T1WI)。目的:本研究旨在评价FLAIR对比增强与T1WI对比增强对颅内肿瘤的诊断价值,为进一步的临床判断提供数据。方法:对88例连续的颅内肿瘤进行对比增强脑MRI分析。FLAIR和T1以相等的百分比交替使用作为第一个对比增强序列,以避免病变的延迟对比增强效果。考虑了六个定量标准:病变与白质对比度(CR)和对比噪声比(CNR),病变与灰质对比度和CNR,以及病变与脑脊液对比度和CN。为了进行定性评估,两名经验丰富的放射科医生使用以下三个量表评估对比增强T1WI和FLAIR序列上的病变显著性:1,FLAIR优;2、序列相等;3、T1优。结果:在定量测量方面,对比度增强的FLAIR病变至白质、病变至脑脊液CR和CNR值在统计学上优于对比度增强T1加权图像(全部p=0.001)。然而,CE-FLAIR对灰质CR和CNR的损伤略高,但无统计学显著差异(分别为p=0.159和0.184)。对于定性评估,两位放射科医生都评估了对比度增强的FLAIR图像在评估病变显著性方面优于对比度增强T1加权图像,尤其是当它作为第二序列进行时。结论:FLAIR序列优于或可与T1序列相比较,尤其是当作为第二个对比后序列时。使用对比增强FLAIR作为常规MRI序列将提高诊断信心。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Rwanda Medical Journal
Rwanda Medical Journal Medicine-Medicine (all)
CiteScore
0.20
自引率
0.00%
发文量
31
审稿时长
7 weeks
期刊介绍: The Rwanda Medical Journal (RMJ), is a Not-For-Profit scientific, medical, journal that is published entirely online in open-access electronic format. The RMJ is an interdisciplinary research journal for publication of original work in all the major health disciplines. Through a rigorous process of evaluation and peer review, The RMJ strives to publish original works of high quality for a diverse audience of healthcare professionals. The Journal seeks to deepen knowledge and advance scientific discovery to improve the quality of care of patients in Rwanda and internationally.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信